Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
3
43%
Ph phase_3
2
29%
Ph phase_4
1
14%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Terminated1
Not yet recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (33.3%)
Phase 41 (16.7%)
N/A3 (50.0%)

Trials by Status

terminated114%
not_yet_recruiting114%
unknown114%
withdrawn114%
completed343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7